PHA Copolymer Biosynthesis With Long-Chain 3HA for Low-Temperature Strength

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing PHA copolymers fail to produce a PHA copolymer containing a high proportion of 3-hydroxyalkanoate monomer units having 8 or more carbon atoms in the polyhydroxyalkanoate copolymer, resulting in the need for improved mechanical properties in low-temperature environments.

Innovation Solution

A polyhydroxyalkanoate polymer production method involving the use of a transformed microorganism having an introduced exogenous gene encoding a Class 2 PhaC derived from the genus Mycobacterium, Mycolicibacterium, or Nocardioides. The polymerization of the polyhydroxyalkanoate polymer is produced by culturing a transformed microorganism having an introduced exogenous gene encoding a Class 2 PhaC derived from the genus Mycobacterium, Mycolicibacterium, or Nocardioides. The polymerization of the polyhydroxyalkanoate polymer is produced by culturing a transformed microorganism having an introduced gene encoding a Class 2 PhaC derived from the genus Mycobacterium, Mycobacterium, or Nocardioides. The polymerization of the polyhydroxyalkanoate polymer is produced by culturing a transformed microorganism having an introduced gene encoding a Class 2 PhaC derived from the genus Mycobacterium, Mycolicibacterium, or Nocardioides.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If PHAs composed of 3-hydroxyalkanoate monomer units having 4 to 6 carbon atoms are produced, then the PHA can be manufactured using existing methods, but the glass transition temperature is around 0°C and mechanical properties decline in low-temperature environments

Engineering Contradiction:
ImprovemanufacturabilityVSAvoidglass transition temperature
Core Design Contradiction:
Ease of manufactureVSTemperature

Solution Approach 1:

The patent changes the carbon atom parameter of the monomer units from 4-6 carbon atoms to 8 or more carbon atoms (medium-chain-length 3HAs). This parameter change directly lowers the glass transition temperature while maintaining manufacturability through the transformed microorganism system

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite PHA copolymer structure containing both 3HB units and medium-chain-length 3HA units (8 or more carbon atoms). This composite structure combines the benefits of existing PHA manufacturability with the low glass transition temperature properties of medium-chain-length monomers

Inventive Principle:
Principle #40Composite materials

2Productivity

If Class 2 PhaC from Pseudomonas genus is introduced to produce PHA copolymer containing medium-chain-length 3HA monomer units, then polymerization activity for 6 to 14 carbon atoms is achieved, but the proportion of 3HA monomer units having 8 or more carbon atoms in the copolymer is insufficient

Engineering Contradiction:
Improvepolymerization activityVSAvoidmonomer unit proportion
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent applies local quality by selecting specific Class 2 PhaC enzymes from particular genera (Mycobacterium, Mycolicibacterium, or Nocardioides) that have optimized catalytic properties for incorporating medium-chain-length 3HA units. This localized enzyme selection achieves both high polymerization activity and precise control over monomer unit proportion

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The transformed microorganism system incorporates feedback mechanisms where the introduced Class 2 PhaC gene from specific genera produces enzymes that selectively polymerize medium-chain-length 3HA monomers, thereby controlling the final copolymer composition to contain a high proportion of 8 or more carbon atom units

Inventive Principle:
Principle #23Feedback

3Productivity

If conventional methods using Pseudomonas or introduced Class 2 PhaC genes are used, then PHA copolymer production is achieved, but the proportion of 3-hydroxyalkanoate monomer units having 8 or more carbon atoms fails to be sufficiently high

Engineering Contradiction:
ImprovePHA copolymer productionVSAvoidmonomer unit composition
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent changes the genetic parameter by introducing Class 2 PhaC genes from specific genera (Mycobacterium, Mycolicibacterium, or Nocardioides) into the microorganism. This genetic parameter change results in enzymes that produce copolymers with sufficiently high proportions of medium-chain-length monomer units while maintaining high productivity

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The polymerization of the polyhydroxyalkanoate polymer is improved by using a transformed microorganism that can produce a polyhydroxyalkanoate polymer containing a high proportion of 3-hydroxyalkanoate monomer units having 8 or more carbon atoms, resulting in improved mechanical properties in low-temperature environments.

Implementation Method 1

PhaCs of Class 2 have polymerization activity for 3-hydroxyalkanoates having 6 to 14 carbon atoms

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentEP4660309A1Transformed microorganism, and method for producing copolymerized polyhydroxyalkanoate
Publication Date: 2025.12.10 KANEKA CORP
  • EP4660309A1 patent drawing
  • EP4660309A1 patent drawing
  • EP4660309A1 patent drawing

AI summary

A transformed microorganism having an ability to produce a polyhydroxyalkanoate copolymer containing 3-hydroxyalkanoate monomer units having 8 or more carbon atoms includes: an exogenous gene encoding a polyhydroxyalkanoate synthase having an amino acid sequence of any one of SEQ ID NOS: 1 to 4; or an exogenous gene encoding a protein that has an amino acid sequence having a sequence identity of at least 90% with the amino acid sequence of any one of SEQ ID NOS: 1 to 4 and that has polyhydroxyalkanoate synthase activity.